USP

PRESS RELEASE Rockville, MD, July 11, 2023 – The U.S. Pharmacopeia (USP) and The National Institute for Pharmaceutical Technology and Education (NIPTE) today announced the official launch of their jointly-developed Continuous Manufacturing Knowledge Center (CMKC). The online platform is designed…
Read More...

USP has launched the newest tool in their suite of solutions to address the evolving nitrosamines crisis: the Nitrosamines Analytical Hub, a public, web-based repository of downloadable analytical procedures to test for nitrosamine impurities and related substances in pharmaceuticals. In recent…
Read More...

In industrial practice, the development of pharmaceutical dry granulation processes typically involves time- and resource-intensive multivariate experiments. These experiments are used to identify the set of operating conditions, their allowed ranges and chosen setpoints where the desired product…
Read More...

Through the World Health Organization, ten international pharmacopeias—including USP—have collaborated to publish this interactive dashboard of active pharmaceutical ingredients and monographs for existing generic drugs being investigated as COVID-19 treatments. For any medicine to be safe and…
Read More...

USP is interested in hosting a Virtual Round Table concerning the modernization of this monograph. We encourage all to participate to help us ensure the quality of medicines for our global patients! If your company manufactures Xanthan Gum as a a pharmaceutical excipient a food ingredient…
Read More...

The COVID19 pandemic is testing global medical supply chains. Read the new US Pharmacopeia paper on Pandemic Preparedness for Regulators in Low- and Middle-Income Countries. This is the first one in the new series on pandemic preparedness for regulators in LMICs, which frames how regulatory…
Read More...

Do you want to use the USP Pending Monograph process? Or have you ever wondered what the USP Pending Monograph process is and how it works in detail? See our article explaining the PMP with a full overview or have a look at our summarizing video. Both are based on USP information. Moreover, you can…
Read More...

Article By Dr. Catherine Sheehan - Senior Director of Science – Excipients at the United States Pharmacopeial Convention With significant innovations in pharmaceuticals, including biologic drugs and treatments for rare diseases, the need for new and better functioning excipients to improve drug…
Read More...